Market closedNon-fractional

CareDx/CDNA

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About CareDx

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre-and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates major revenue from the Testing services.

Ticker

CDNA

Sector

Healthcare

Trading on

NASDAQ

Industry

Biotechnology

Headquarters

South San Francisco, United States

Employees

639
Website
caredx.com

CareDx Metrics

BasicAdvanced
$830M
Market cap
-
P/E ratio
-$3.44
EPS
1.77
Beta
-
Dividend rate
$830M
1.77
4.317
3.932
10.496
12.859
-12.63%
-54.18%
3.081
3.23
4.79
-20.026
-13.93%
127.76%
7.54%
130.87%

What the Analysts think about CareDx

Analyst Ratings

Majority rating from 7 analysts.
Buy

CareDx Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-23.05% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$72M
9.92%
Net income
-$17M
-85.93%
Profit margin
-23.05%
-87.21%

CareDx Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 85.44%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.18
-$0.18
-$0.17
-$0.03
-
Expected
-$0.31
-$0.40
-$0.27
-$0.21
-$0.15
Surprise
-41.94%
-54.48%
-36.19%
-85.44%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for CareDx stock?

CareDx (CDNA) has a market cap of $830M as of July 14, 2024.

What is the P/E ratio for CareDx stock?

The price to earnings (P/E) ratio for CareDx (CDNA) stock is 0 as of July 14, 2024.

Does CareDx stock pay dividends?

No, CareDx (CDNA) stock does not pay dividends to its shareholders as of July 14, 2024.

When is the next CareDx dividend payment date?

CareDx (CDNA) stock does not pay dividends to its shareholders.

What is the beta indicator for CareDx?

CareDx (CDNA) has a beta rating of 1.77. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

Buy or sell CareDx stock

Buy or sell CareDx stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing